Company: MYSZ
Filing Date: 2025-03-27
Form Type: 10-K
Source: 0001641172-25-000990
Chunk: 143

Company: My Size, Inc.
Filing Date: 2025-03-27
Form: 10-K
Item: Item 1C
Chunk 143
---
arrants”), and (ii) 47,153
    shares of the Company’s common stock issued on October 28, 2021 at an exercise price of $31.50
    per share, having terms ranging from 28 months to five and one-half years (the “October 2021 Warrants” and together with
    the January 2023 Warrants and the January 2020 Warrants, the “2023 Existing Warrants). Pursuant to the 2023 Inducement Letter,
    the holder agreed to exercise for cash its 2023 Existing Warrants to purchase an aggregate of 2,018,012
    shares of the Company’s common stock at a reduced exercise price of $2.09
    per share in consideration of the Company’s agreement to issue new common stock purchase warrants to purchase up to an
    aggregate of 5,367,912
    shares of the Company’s common stock at an exercise price of $2.09
    per share. The Company received aggregate gross proceeds of approximately $4.2
    million from the exercise of the 2023 Existing Warrants by the holder, before deducting placement agent fees and other offering
    expenses payable by the Company. The net proceeds were approximately $3.6
    million.   As of December 31, 2024, the Company issued to the holder all of the exercised shares.

    d.
    On
    May 16, 2024, the Company entered into an inducement offer letter agreement (the “2024 Inducement Letter”) with a
    certain holder of certain of the Company’s existing warrants to purchase up to (i) 326,514
    shares of the Company’s common stock issued on August 28, 2023 with a twenty-eight month term at an exercise price of $16.72
    per share, and (ii) 344,475
    shares of the Company’s common stock issued on August 28, 2023 with a five and one-half year term at an exercise price of
    $16.72
    per share, ((i) and (ii) collectively, the “ 2024 Existing Warrants).

    Pursuant
    to the 2024 Inducement Letter, the holder agreed to exercise for cash its 2024 Existing Warrants to purchase an aggregate of 670,989
    shares of the Company’s common stock at a reduced exercise price of $4